
A novel antimicrobial peptide, LC-AMP-I1, derived from Lycosa coelestis venom, exhibited strong antibacterial and anti-biofilm activities against multidrug-resistant bacteria. It demonstrated minimal bacterial resistance, low cytotoxicity, excellent stability, and negligible hemolytic activity. LC-AMP-I1 enhanced therapeutic efficacy in combination with traditional antibiotics and showed promising in vivo effects in a neutropenic mouse infection model. Mechanistically, LC-AMP-I1 disrupts bacterial membranes, making it a potential alternative to traditional antibiotics for combating antibiotic resistance.
Like
Save
Share